267 related articles for article (PubMed ID: 29348456)
1. TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis.
Grither WR; Divine LM; Meller EH; Wilke DJ; Desai RA; Loza AJ; Zhao P; Lohrey A; Longmore GD; Fuh KC
Oncogene; 2018 Mar; 37(13):1714-1729. PubMed ID: 29348456
[TBL] [Abstract][Full Text] [Related]
2. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.
Wang YG; Xu L; Jia RR; Wu Q; Wang T; Wei J; Ma JL; Shi M; Li ZS
Dig Dis Sci; 2016 Aug; 61(8):2272-2283. PubMed ID: 27010547
[TBL] [Abstract][Full Text] [Related]
3. Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial-mesenchymal transition programme under hypoxia.
Ren T; Zhang W; Liu X; Zhao H; Zhang J; Zhang J; Li X; Zhang Y; Bu X; Shi M; Yao L; Su J
J Pathol; 2014 Dec; 234(4):526-37. PubMed ID: 25130389
[TBL] [Abstract][Full Text] [Related]
4. The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis.
Zhang K; Corsa CA; Ponik SM; Prior JL; Piwnica-Worms D; Eliceiri KW; Keely PJ; Longmore GD
Nat Cell Biol; 2013 Jun; 15(6):677-87. PubMed ID: 23644467
[TBL] [Abstract][Full Text] [Related]
5. Discoidin Domain Receptor 2 Mediates Lysophosphatidic Acid-Induced Ovarian Cancer Aggressiveness.
Jeong BY; Cho KH; Yoon SH; Park CG; Park HW; Lee HY
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065317
[TBL] [Abstract][Full Text] [Related]
6. Role of discoidin domain receptor 2 (DDR2) and microRNA-182 in survival of women with high-grade serous ovarian cancer.
Ramalho S; Andrade LAA; Filho CC; Natal RA; Pavanello M; Ferracini AC; Sallum LF; Sarian LO; Derchain S
Tumour Biol; 2019 Jan; 41(1):1010428318823988. PubMed ID: 30810094
[TBL] [Abstract][Full Text] [Related]
7. DDR2-regulated arginase activity in ovarian cancer-associated fibroblasts promotes collagen production and tumor progression.
Akinjiyan FA; Ibitoye Z; Zhao P; Shriver LP; Patti GJ; Longmore GD; Fuh KC
Oncogene; 2024 Jan; 43(3):189-201. PubMed ID: 37996700
[TBL] [Abstract][Full Text] [Related]
8. Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition.
Tseng WC; Chuang CW; Yang MH; Pan CC; Tarng DC
Urol Oncol; 2016 Nov; 34(11):485.e15-485.e24. PubMed ID: 27519276
[TBL] [Abstract][Full Text] [Related]
9. Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins.
Schab AM; Greenwade MM; Stock E; Lomonosova E; Cho K; Grither WR; Noia H; Wilke D; Mullen MM; Hagemann AR; Hagemann IS; Thaker PH; Kuroki LM; McCourt CK; Khabele D; Powell MA; Mutch DG; Zhao P; Shriver LP; Patti GJ; Longmore GD; Fuh KC
Mol Cancer Res; 2023 Nov; 21(11):1234-1248. PubMed ID: 37527178
[TBL] [Abstract][Full Text] [Related]
10. The Action of Discoidin Domain Receptor 2 in Basal Tumor Cells and Stromal Cancer-Associated Fibroblasts Is Critical for Breast Cancer Metastasis.
Corsa CA; Brenot A; Grither WR; Van Hove S; Loza AJ; Zhang K; Ponik SM; Liu Y; DeNardo DG; Eliceiri KW; Keely PJ; Longmore GD
Cell Rep; 2016 Jun; 15(11):2510-23. PubMed ID: 27264173
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tumor-microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain.
Grither WR; Longmore GD
Proc Natl Acad Sci U S A; 2018 Aug; 115(33):E7786-E7794. PubMed ID: 30061414
[TBL] [Abstract][Full Text] [Related]
12. DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study.
Tsai MC; Li WM; Huang CN; Ke HL; Li CC; Yeh HC; Chan TC; Liang PI; Yeh BW; Wu WJ; Lim SW; Li CF
Oncotarget; 2016 Nov; 7(48):78918-78931. PubMed ID: 27793038
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stem Cell-Induced DDR2 Mediates Stromal-Breast Cancer Interactions and Metastasis Growth.
Gonzalez ME; Martin EE; Anwar T; Arellano-Garcia C; Medhora N; Lama A; Chen YC; Tanager KS; Yoon E; Kidwell KM; Ge C; Franceschi RT; Kleer CG
Cell Rep; 2017 Jan; 18(5):1215-1228. PubMed ID: 28147276
[TBL] [Abstract][Full Text] [Related]
14. Discoidin Domain Receptor 2: A New Target in Cancer.
Xu X; Yu T; Wang Z
Oncol Res Treat; 2022; 45(4):205-215. PubMed ID: 35073544
[TBL] [Abstract][Full Text] [Related]
15. DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway.
Lin CC; Yang WH; Lin YT; Tang X; Chen PH; Ding CC; Qu DC; Alvarez JV; Chi JT
Oncogene; 2021 Mar; 40(11):2018-2034. PubMed ID: 33603168
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer.
Kobayashi-Watanabe N; Sato A; Watanabe T; Abe T; Nakashima C; Sueoka E; Kimura S; Sueoka-Aragane N
Lung Cancer; 2017 Aug; 110():35-41. PubMed ID: 28676216
[TBL] [Abstract][Full Text] [Related]
17. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
[TBL] [Abstract][Full Text] [Related]
18. Discoidin Domain Receptors, DDR1b and DDR2, Promote Tumour Growth within Collagen but DDR1b Suppresses Experimental Lung Metastasis in HT1080 Xenografts.
Wasinski B; Sohail A; Bonfil RD; Kim S; Saliganan A; Polin L; Bouhamdan M; Kim HC; Prunotto M; Fridman R
Sci Rep; 2020 Feb; 10(1):2309. PubMed ID: 32047176
[TBL] [Abstract][Full Text] [Related]
19. DDR2 inhibition reduces migration and invasion of murine metastatic melanoma cells by suppressing MMP2/9 expression through ERK/NF-κB pathway.
Poudel B; Lee YM; Kim DK
Acta Biochim Biophys Sin (Shanghai); 2015 Apr; 47(4):292-8. PubMed ID: 25733533
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability.
Badiola I; Villacé P; Basaldua I; Olaso E
Oncol Rep; 2011 Oct; 26(4):971-8. PubMed ID: 21701781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
